Welcome to our dedicated page for Vital Farms SEC filings (Ticker: VITL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vital Farms, Inc. (Nasdaq: VITL) is a Certified B Corporation and Delaware public benefit corporation that focuses on pasture-raised eggs and egg-based foods such as shell eggs, butter, hard-boiled eggs, and liquid whole eggs. As a publicly traded company, Vital Farms files regular reports and current reports with the U.S. Securities and Exchange Commission (SEC), providing detailed information on its financial performance, risks, governance, and strategic initiatives.
On this page, you can review Vital Farms’ SEC filings, including annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its business model, farm network, product categories, and risk factors related to supply, consumer demand, agricultural disease, regulation, and macroeconomic conditions. These filings also discuss its status as a public benefit corporation, its stakeholder-focused objectives, and its emphasis on humane treatment of farm animals and sustainable farming practices.
Current reports on Form 8-K offer more immediate updates. Recent 8-K filings have covered quarterly financial results, long-term net revenue targets, and governance matters such as the appointment of a new independent director and the frequency of advisory Say-on-Pay votes. An amended 8-K explains the company’s decision to hold non-binding advisory votes on executive compensation annually, following stockholder preferences.
Stock Titan’s platform enhances access to these documents with AI-powered summaries that explain key sections of Vital Farms’ filings in plain language. Investors can quickly understand highlights from lengthy 10-K and 10-Q reports, see what management disclosed in 8-K earnings releases, and track governance items without reading every page. Real-time updates from EDGAR ensure that new filings appear promptly, while AI-generated overviews help readers identify significant changes, recurring themes, and references to long-term targets and capital projects.
For users monitoring insider and governance activity, this page also centralizes access to forms and disclosures related to directors and executive compensation policies as referenced in Vital Farms’ filings.
Vital Farms, Inc. reported insider equity activity by its CLO, Secretary & Head of Impact, Joanne Bal. On March 5, 2026, she acquired 15,184 shares of common stock as a restricted stock unit (RSU) award at a stated price of $0.00 per share, bringing her reported holdings after that award to 57,990 shares.
The RSU grant vests in three equal annual installments starting on March 5, 2027, conditioned on her continued service with the company on each vesting date. On March 4, 2026, 784 shares were disposed of at $20.30 per share to satisfy withholding tax obligations, leaving 42,806 shares reported as directly owned after that tax-withholding transaction.
Vital Farms, Inc. director and President, CEO & Exec. Chair Russell Diez-Canseco reported two stock transactions involving the company’s common stock. On March 5, 2026, he acquired 75,415 shares at $0.00 per share as a restricted stock unit (RSU) award that vests in three equal annual installments starting on March 5, 2027, subject to continued service.
On March 4, 2026, he disposed of 2,855 shares at $20.30 per share through a tax-withholding disposition, where shares were withheld by Vital Farms to satisfy withholding tax obligations. After these transactions, his directly held common stock positions reported in the filing were updated accordingly.
Vital Farms, Inc. reported that Chief Supply Chain Officer Joseph Michael Holland had two equity transactions in common stock. On March 5, 2026, he acquired 15,184 shares as a restricted stock unit (RSU) award at $0.00 per share, increasing his direct holdings to 25,666 shares. The RSUs vest in three equal annual installments beginning on March 5, 2027, conditioned on his continued service. On March 4, 2026, 969 shares were disposed of at $20.30 per share to satisfy withholding tax obligations, leaving him with 10,482 directly held shares after that tax-withholding transaction.
Vital Farms, Inc. reported insider equity activity involving Chief Strategy Officer Stephanie Coon. She received a grant of 13,675 shares of common stock as a restricted stock unit (RSU) award at a stated price of $0.0000 per share. According to the terms, these RSUs vest in three equal annual installments starting on March 5, 2027, contingent on her continued service with the company.
Separately, 745 shares of common stock were disposed of at $20.30 per share to satisfy a withholding tax obligation, with the shares withheld by the company rather than sold in the open market. Following these transactions, her reported direct holdings in common stock changed as reflected in the filing’s share totals.
Vital Farms, Inc. director William B. Cyr bought 4,750 shares of common stock in an open-market purchase on March 2, 2026 at a weighted average price of $20.70 per share. The trades occurred at prices ranging from $20.58 to $20.71. After this transaction, he directly owns 7,794 shares.
Vital Farms, Inc. major stockholder Matthew Ohayer reported an open-market sale of 20,000 shares of common stock at a weighted-average price of $20.33 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2025.
After this sale, Ohayer directly owned 6,321,190 common shares. The filing also notes indirect ownership of 400,000 shares held by a former spouse, over which he has sole voting control but no pecuniary interest.
VITL filing notifies a proposed sale of 27,660 shares of common stock to be sold by the issuer upon restricted stock vesting on 03/03/2026. The filing also reports prior sales of 16,734 shares on 12/15/2025 for $586,526.70.
VITL-related filer reports a proposed sale of 45,000 common shares. The filing lists prior 10b5-1 sales by Matthew Ohayer totaling individual transactions of 5,000 on 12/15/2025, 25,000 on 01/02/2026, and 20,000 on 02/02/2026 with proceeds shown as $176,250, $771,371, and $558,215 respectively.
Vitl submitted a Section 144 notice describing a proposed sale of 45,000 common shares through Morgan Stanley Smith Barney LLC.
The filing also lists recent 10b5-1 sales by Matthew Ohayer: 5,000 shares on 12/15/2025, 25,000 shares on 01/02/2026, and 20,000 shares on 02/02/2026, with proceeds shown for each sale.
Vital Farms, Inc. files its annual report describing a fast-growing, mission-driven pasture-raised egg and butter business built around more than 600 small family farms and a central processing hub in Missouri, with a second egg washing and packing facility under construction in Indiana.
The company increased net revenue from $260.9 million in fiscal 2021 to $759.4 million in fiscal 2025, a 30.6% CAGR, and sells through over 24,000 U.S. retail stores plus a growing foodservice channel. As of February 23, 2026, it had 44,797,125 common shares outstanding, and non‑affiliate equity was valued at approximately $1.4 billion as of June 29, 2025. Management emphasizes Conscious Capitalism, Certified B Corporation and Delaware public benefit corporation status, outlining impact goals around climate, regenerative agriculture and crew culture, alongside extensive risk disclosures on supply chain capacity, avian disease, commodity price swings, retailer concentration and execution of its planned Vital Crossroads facility.